ライフサイエンスコーパス: clinicopathological

1 ic extramedullary hematopoiesis, and altered clinicopathological abnormalities during mammalian colon

2 Parkinson's disease is not fully understood, clinicopathological analyses have led to the development

3 We integrated genomic and clinicopathological analyses of a cohort of patients wit

4 Furthermore, results from clinicopathological analysis revealed that elevated Cdh1

5 Upon clinicopathological analysis, the presence of natural CO

6 or the expression of SALL4 and carried out a clinicopathological analysis.

7 Hairy cell leukemia (HCL) shows unique clinicopathological and biological features.

8 Here, by correlating clinicopathological and expression data, we demonstrate

9 ily more possible to tailor treatment to the clinicopathological and immunogenetic profile of the ind

10 he objective of this study is to analyze the clinicopathological and immunohistochemical characterist

11 Clinicopathological and laboratory parameters were colle

12 We studied the clinicopathological and molecular characteristics of six

13 s of the lung (SQCLCs) are defined by unique clinicopathological and molecular characteristics that h

14 ays in the tumorigenesis of ACC, we examined clinicopathological and molecular data and used mouse mo

15 g these novel subgroups along with secondary clinicopathological and molecular features and establish

16 model and investigated for associations with clinicopathological and molecular features including age

17 We investigated the clinicopathological and molecular features of 85 resecte

18 Little is known about its clinicopathological and molecular features or its manage

19 These subgroups have distinct clinicopathological and molecular features, and underpin

20 ethylation and CIMP+ tumors have distinctive clinicopathological and molecular features.

21 Collectively, the clinicopathological and molecular findings point to a ca

22 The clinicopathological and molecular heterogeneity of endom

23 se (vCJD) is a unique and highly distinctive clinicopathological and molecular phenotype of human pri

24 Based on a review of recent clinicopathological and molecular studies, we propose a

25 (CDC2, CDC42) and expression correlated with clinicopathological and molecular variables and patient

26 Clinicopathological and outcome data were reviewed, and

27 We used multivariate analyses to evaluate clinicopathological and perioperative factors for associ

28 her these polymorphisms were associated with clinicopathological and phenotypic characteristics and w

29 Clinicopathological and survival data of PDAC patients t

30 enrichment of genetic pathways, and distinct clinicopathological and survival features.

31 Demographic, clinicopathological, and endoscopic data were collected.

32 These results were further confirmed by a clinicopathological assessment in vivo.

33 es a novel contribution to understanding the clinicopathological associations in HD.

34 Certain relatively specific clinicopathological associations were identified.

35 Clinicopathological characterisation and shared haplotyp

36 hemotherapy, and was associated with patient clinicopathological characterisitcs.

37 Clinicopathological characteristics and outcomes were co

38 pecimens and was statistically analyzed with clinicopathological characteristics and patients' surviv

39 genotypes with breast cancer susceptibility, clinicopathological characteristics and prognosis.

40 was used for the correlation with patients' clinicopathological characteristics as a continuous vari

41 The clinicopathological characteristics associated with a SC

42 Clinicopathological characteristics at baseline diagnosi

43 Clinicopathological characteristics of BRAF-mutated CM h

44 Clinicopathological characteristics of MECs was demonstr

45 Program and performed analysis to determine clinicopathological characteristics of PBS and estimate

46 Our study demonstrated clinicopathological characteristics of PBS in the US pop

47 wait period may be required depending on the clinicopathological characteristics of the previous SCC

48 tic features have been identified beyond the clinicopathological characteristics of the primary tumor

49 flu) hospitalized for pneumonia with similar clinicopathological characteristics to those of COVID-19

50 The relationship between PDW and clinicopathological characteristics were analyzed.

51 The relationships between MPV and clinicopathological characteristics were analyzed.

52 riate linear regression models adjusting for clinicopathological characteristics were used to analyze

53 progression-free survival, overall survival, clinicopathological characteristics, and pertuzumab trea

54 mposite ratios and the cumulative scores and clinicopathological characteristics, cancer specific sur

55 Demographics, clinicopathological characteristics, distribution of the

56 After controlling for clinicopathological characteristics, higher BMI was sign

57 Clinicopathological characteristics, perioperative detai

58 On the basis of conventional clinicopathological characteristics, physicians recommen

59 The primary outcome measures were clinicopathological characteristics, usefulness of EVD w

60 Measures: The primary outcome measures were clinicopathological characteristics, usefulness of EVD w

61 at baseline with respect to demographic and clinicopathological characteristics.

62 , and aim to ascertain the relationship with clinicopathological characteristics.

63 human HCC tissue microarray and analysis of clinicopathological characteristics.

64 the presence of the BRAF mutation and other clinicopathological characteristics.

65 ssed, nor has its relationship to presenting clinicopathological characteristics.

66 08) were assessed by genomic analysis and by clinicopathological characterization in specific-pathoge

67 present the complete genome sequence and the clinicopathological characterization of a virulent Newca

68 A large body of clinicopathological, circumstantial, and epidemiological

69 NG, PARTICIPANTS, AND EXPOSURE: Longitudinal clinicopathological cohort study at residences of partic

70 ergence of new fibril conformers with varied clinicopathological consequences.

71 neurodegenerative disease and the nuances of clinicopathological considerations.

72 ting Center autopsy cohort across the entire clinicopathological continuum of AD.

73 ctor for CTE pathological features, although clinicopathological correlates and the nature of onset a

74 cally by noninvasive imaging, the details of clinicopathological correlates have not been described.

75 of the epidemiologic factors, mechanism, and clinicopathological correlates of CTE reflect the curren

76 We investigated the spectrum and clinicopathological correlates of liver pathology in a h

77 plasmic inclusions play an important role in clinicopathological correlates of MSA.

78 at multiple levels and therefore traditional clinicopathological correlation approaches to better cla

79 A clinicopathological correlation between observed retinal

80 Clinicopathological correlation showed that sequestratio

81 agnostic criteria and complement prospective clinicopathological correlation studies.

82 A clinicopathological correlation was performed on 90 cons

83 Disease Center Brain Bank with near-optimal clinicopathological correlation.

84 terized clinical cohorts in order to develop clinicopathological correlations at the synapse level.

85 We report clinicopathological correlations from 79 autopsy cases d

86 improve pathological prediction by exploring clinicopathological correlations in a large bvFTD cohort

87 Clinicopathological correlations in FTLD are subsequentl

88 Clinicopathological correlations with measures of verbal

89 icenter research on treatment interventions, clinicopathological correlations, and studies of cogniti

90 To investigate the spectrum of clinicopathological correlations, we performed a semi-qu

91 tonomously generated K6 antibodies alter the clinicopathological course of disease in murine proteoli

92 tion site of CC) independent of other common clinicopathological covariates.

93 include achieving complete remission (CR) by clinicopathological criteria followed by interrogation f

94 Based on unique clinicopathological criteria, the most common immune inf

95 t to predict based on established prognostic clinicopathological criteria.

96 of public resources including brain samples, clinicopathological data and correlative gene expression

97 Diagnostic clinicopathological data from 10,139 men with non-metast

98 ile for anomalous mitral arcade, we compared clinicopathological data from 11 sets of autopsied twin-

99 Epidemiologic and clinicopathological data from current literature provide

100 b and NonOb groups were comparable regarding clinicopathological data, except for arterial hypertensi

101 umour, with long-term follow-up and complete clinicopathological data.

102 cancer and to evaluate its association with clinicopathological data.

103 e variant did not show associations with the clinicopathological data.

104 d correlated with overall survival and other clinicopathological data.

105 w plasma cells, with long-term follow-up and clinicopathological data.

106 t of the continuously evolving nature of its clinicopathological description over the past decade.

107 ow CERAD/intermediate Braak scores, that is, clinicopathological descriptors of early Alzheimer's dis

108 We detected a lower rate of clinicopathological discrepancy in critically ill patien

109 EE is a clinicopathological disease characterized by (1) Symptom

110 differences in PrP(Sc) might account for the clinicopathological diversity evident in Creutzfeldt-Jak

111 ssociated AIH have been proposed as distinct clinicopathological entities.

112 that corticobasal degeneration is a discrete clinicopathological entity but with a broader clinical s

113 ur findings (i) help to dissect one separate clinicopathological entity from what is likely to be a s

114 The definition of the clinicopathological entity of amyotrophic lateral sclero

115 ic gingival hyperplasia (JSGH) is a distinct clinicopathological entity of the buccal gingiva of youn

116 We describe four cases of a new clinicopathological entity presenting with either a fron

117 associated MCD may be considered as a single clinicopathological entity regardless of HIV status.

118 arch in dementia because they delineated the clinicopathological entity that is now known as Alzheime

119 ersary of Alzheimer's lecture describing the clinicopathological entity which bears his eponym, this

120 Hairy cell leukemia (HCL) is a distinct clinicopathological entity whose underlying genetic lesi

121 ler (NK) T-cell lymphoma (ENKTL) is a unique clinicopathological entity, typically associated with po

122 patients with breast cancer may be guided by clinicopathological factors and a score based on a 21-ge

123 ant qualifying statements outlining relevant clinicopathological factors and details of the reference

124 Clinicopathological factors and long-term survival were

125 Clinicopathological factors and overall outcome was anal

126 Clinicopathological factors and patient outcomes were me

127 criminative plasma miRNA was correlated with clinicopathological factors and survival, and also inves

128 Multivariate analysis including clinicopathological factors as covariates revealed high

129 f patient survival in association with other clinicopathological factors in univariate [hazard ratio

130 efficacy end points adjusted for prognostic clinicopathological factors including PIK3CA genotype.

131 In general, clinicopathological factors known to predict and drive a

132 The influence of clinicopathological factors on local recurrence, distant

133 nal lymph nodes (HR 3.2 95% CI 1.2-8.2) were clinicopathological factors predictive of decreased surv

134 34; 95% CI, 2.53-34.48) after adjustment for clinicopathological factors, and the genetic duet showed

135 The stages were compared with clinicopathological factors, including seizure history a

136 ve upon prognostic information from existing clinicopathological factors, the potential of these nove

137 role of NLR after stratification by several clinicopathological factors.

138 6; 95% CI, 2.97-116.18) after adjustment for clinicopathological factors.

139 ntries, and is influenced by patient age and clinicopathological factors.

140 etastatic disease, with due consideration of clinicopathological factors.

141 in the portal veins (venous metastases) is a clinicopathological feature of metastatic HCCs.

142 luation of quantitative ERG1 expression with clinicopathological features also suggested that ERG1 ex

143 CXCR6 in prostate cancer (PC) was related to clinicopathological features and activation of inflammat

144 No significant associations between clinicopathological features and KRAS/BRAF/GNAS genetic

145 BRAF mutation status was compared with clinicopathological features and other genetic alteratio

146 tem, with significant correlations to poorer clinicopathological features and patient survival.

147 There were more correlations between clinicopathological features and the loss of heterozygos

148 Participant clinicopathological features are more consistent with co

149 There were no significant differences in clinicopathological features at initial diagnosis and at

150 c loss of each xenografted cancer with known clinicopathological features for each patient and found

151 ight therefore contribute to the distinctive clinicopathological features in GISTs with different mut

152 n stromal genomic alterations and presenting clinicopathological features in sporadic breast cancer.

153 rosing cholangitis, a syndrome with distinct clinicopathological features including steroid responsiv

154 In addition, new insights into key clinicopathological features including symptoms such as

155 ese microenvironmental alterations relate to clinicopathological features is unknown.

156 We present the clinicopathological features of 20 Mexican children with

157 The aim of this study was to evaluate clinicopathological features of AA patients diagnosed wi

158 itical roles in the disease by linking other clinicopathological features of Alzheimer's disease.

159 oid-beta species respectively correlate with clinicopathological features of Alzheimer's disease.

160 btaining an overview of the epidemiology and clinicopathological features of BCC in the very elderly

161 of S100 in different intrinsic subtypes and clinicopathological features of breast cancer.

162 focused on identifying genes associated with clinicopathological features of HCC patients.

163 whose expression pattern is associated with clinicopathological features of HCC tumors.

164 urpose of this study was to characterize the clinicopathological features of invasive carcinomas aris

165 This study aims to characterize clinicopathological features of large flat colonic polyp

166 define the risk factors for progression, the clinicopathological features of PD, and the outcomes for

167 regulators were assessed and correlated with clinicopathological features of the patients.

168 We present the clinicopathological features of two siblings from a cons

169 ementia (HAD), a neurological condition with clinicopathological features similar to Alzheimer's dise

170 gy in early stage cancers but not with other clinicopathological features such as patient gender, age

171 ement has been challenged because these show clinicopathological features that are similar to branch

172 between PD-L1 protein expression, TILs, and clinicopathological features were determined.

173 erythematous patches and has shown to share clinicopathological features with rectal prolapse, proct

174 isease has been limited by the heterogeneous clinicopathological features, difficulty in creating ani

175 h the stroma and epithelium, with presenting clinicopathological features, such as tumor grade, expre

176 expressed in the subgroups with "aggressive" clinicopathological features, was associated with an ele

177 splaying a somewhat unusual constellation of clinicopathological features, which overall subserve to

178 ively correlated with tumor stages and other clinicopathological features.

179 and found strong correlations with relevant clinicopathological features.

180 dvanced disease at baseline and more adverse clinicopathological features.

181 gression grading was not associated with any clinicopathological features.

182 elapse risk scores based on their respective clinicopathological features.

183 the BRAF mutation was also compared with the clinicopathological features.

184 with recurrence-free survival, or with other clinicopathological features.

185 18q loss status was not associated with any clinicopathological features.

186 an tumors revealed several associations with clinicopathological features.

187 (PTFL) is a B-cell lymphoma with distinctive clinicopathological features.

188 of follicular lymphoma (FL) with distinctive clinicopathological features.

189 ral therapy and cotrimoxazole was a frequent clinicopathological finding; Mycobacterium tuberculosis

190 e purpose of this study was to correlate the clinicopathological findings and viral antigen distribut

191 With regard to skin blistering, the clinicopathological findings expand the molecular basis

192 f the MDR1 promoter and its correlation with clinicopathological findings were evaluated in 177 prost

193 followed an unusual course and had uncommon clinicopathological findings.

194 matosis is now a complex entity with various clinicopathological forms based on mutations in the HFE

195 pread of pathological protein inclusions and clinicopathological heterogeneity are well described in

196 xpression in 286 invasive breast tumors with clinicopathological, hypoxia markers and survival.

197 Muc-ICCs had a clinicopathological, immunohistochemical, and molecular

198 mparing their mRNA profiles with established clinicopathological indicators and mRNA profiles of estr

199 446 MBCs on tissue microarrays and assessed clinicopathological information, together with data from

200 high despite using only routinely collected clinicopathological information.

201 The cases provide novel clinicopathological insight, for two further reasons: bo

202 Early clinicopathological investigations highlighted a number

203 these data were tested for associations with clinicopathological markers, disease-free survival, and

204 ted fibroblasts (CAFs) and assessed links to clinicopathological markers, prognostic and treatment-pr

205 higher area under the curve compared with a clinicopathological model (0.90 [95% CI 0.78-0.96] vs 0.

206 ved by addition of baseline CTC count to the clinicopathological models (progression-free survival LR

207 value of CTCs or serum markers to prognostic clinicopathological models in a resampling procedure usi

208 ntrally reviewed Ki67 significantly improves clinicopathological models to determine distant recurren

209 en use its output for survival analysis with clinicopathological multivariable adjustment in 7 indepe

210 Emerging evidence from epidemiological, clinicopathological, neuroimaging, biomarker, and experi

211 however no other significant differences in clinicopathological or molecular features were apparent.

212 This is likely to specifically reflect the clinicopathological overlap of ALS with frontotemporal d

213 amyotrophic lateral sclerosis, which shares clinicopathological overlap with FTD) was 3.1 (95% CI 1.

214 Clinicopathological papers on several forms of non-HFE h

215 rcinomas were subcategorized on the basis of clinicopathological parameters (tumor primary site, hist

216 Data were correlated with clinicopathological parameters and patient outcomes.

217 han currently used postoperatively available clinicopathological parameters and potentially could be

218 resent, tumor grade and size are the primary clinicopathological parameters commonly used to guide de

219 HER2 status was confronted with clinicopathological parameters in order to assess statis

220 Clinicopathological parameters included LN status (N0/N1

221 h of tumor infiltration alone but additional clinicopathological parameters should also be considered

222 Similarly, patients differ in their clinicopathological parameters, but how genotypic and ph

223 y assignment with and without adjustment for clinicopathological parameters, including centrally revi

224 isk can be further stratified by a number of clinicopathological parameters.

225 atterns of multiple miRNAs combined with the clinicopathological parameters.

226 rived from the smoker patients and with poor clinicopathological parameters.

227 In this case, we present a novel clinicopathological pattern of AL amyloidosis.

228 ifferentiation facilitates prediction of the clinicopathological phenotype and duration of the diseas

229 Human prion diseases, although variable in clinicopathological phenotype, generally present as neur

230 rther insight into the generation of diverse clinicopathological phenotypes associated with inherited

231 lar mechanism for generation of the multiple clinicopathological phenotypes seen in inherited prion d

232 tle is known on the link between strains and clinicopathological phenotypes, we studied potential str

233 metastatic breast cancer when added to full clinicopathological predictive models, whereas serum tum

234 ewed our experience with the aim to identify clinicopathological predictors of disease recurrence.

235 ts suggest that Richardson syndrome can be a clinicopathological presentation of corticobasal degener

236 Although clinicopathological presentations of GC are known to var

237 ed independent prognostic information to the clinicopathological prognostic factors.

238 pse risk scores to refine prognosis with the clinicopathological prognostic model alone.

239 multivariate analysis including established clinicopathological prognostic variables (HRRav, 0.67; P

240 To date only a small number of anecdotal clinicopathological relations have been reported; neuroi

241 try, however, suggests that these concordant clinicopathological relationships are not universal and

242 We investigated the clinicopathological relevance of SPAG5 gene copy number

243 The underlying signalling pathways, of major clinicopathological relevance, are unknown.

244 We aimed to provide a clinicopathological report of severe COVID-19 cases by d

245 ity of JAK inhibition to induce molecular or clinicopathological responses in MPNs suggests a need fo

246 The classifier and the clinicopathological risk factors (tumour stage, grade, a

247 bias, associate with survival independent of clinicopathological risk factors, and may provide a gene

248 tic factor in patients who otherwise had few clinicopathological risk factors; therefore, the CD68 sc

249 ic gland polyps (FGPs) occur in two distinct clinicopathological scenarios: sporadic and familial ade

250 SP was higher than most previous prospective clinicopathological series and studies using the retrosp

251 Large clinicopathological series have been published that have

252 screening of novel molecules in a simulated clinicopathological setting.

253 However, the clinicopathological significance and prognostic value of

254 In short, our data provided clinicopathological significance for STIM1 and SOCE in C

255 analyses on 125 primary tumours to evaluate clinicopathological significance of molecular subgroup a

256 Our study aimed to investigate the clinicopathological significance of SATB1 in a cohort of

257 The aim of this study was to investigate the clinicopathological significance of these molecular subt

258 ole of Pin1 in human PCa progression and its clinicopathological significance.

259 The clinicopathological similarities between lichen sclerosu

260 ressive language problems falling within the clinicopathological spectrum of frontotemporal lobar deg

261 ee of 74 colon cancer patients were of known clinicopathological stage.

262 and OCT4 levels positively correlated to the clinicopathological stages of HCC patients.

263 Clinicopathological studies are important in determining

264 We suggest that additional clinicopathological studies be performed in patients wit

265 h dementia live in developing countries, few clinicopathological studies focus on these individuals.

266 Recent clinicopathological studies have now also demonstrated t

267 Clinicopathological studies in four HIV-infected patient

268 white matter hyperintensities, we performed clinicopathological studies in post-stroke survivors, wh

269 oject (mean age, 88.0 years), a longitudinal clinicopathological study.

270 from a large, longitudinal, epidemiological clinicopathological study.

271 tient mortality was also observed in several clinicopathological subcategories, but statistical signi

272 favoured the CDKI group in all prespecified clinicopathological subgroups analysed, with similar HRs

273 I to endocrine therapy seemed to benefit all clinicopathological subgroups of interest in this pooled

274 Two clinicopathological subtypes are recognized: type I (end

275 support the hypothesis that AD has distinct clinicopathological subtypes.

276 MSA has been divided into two clinicopathological subtypes: MSA with predominant parki

277 etween EBV infection and HP infection or any clinicopathological variable was detected.

278 Clinicopathological variables and genetic alterations we

279 on of POLE proofreading domain mutation with clinicopathological variables and immune response in col

280 Adjusting for clinicopathological variables and treatment arms, ERBB2/

281 variable analysis was performed to determine clinicopathological variables correlated with ypN0.

282 d with breast cancer pathogenesis or several clinicopathological variables including receptor status

283 The clinicopathological variables of 59 patients resected fo

284 olecular markers tested were correlated with clinicopathological variables of the cohort, including t

285 les that reported the influence of 1 or more clinicopathological variables on overall survival after

286 Clinicopathological variables used at present for progno

287 Fifteen clinicopathological variables were analyzed to evaluate

288 Clinicopathological variables, including TNM stage, hist

289 ct on survival, and were not associated with clinicopathological variables, patients with exon9 charg

290 fications was independent of tissue-specific clinicopathological variables, the proliferation marker

291 arkers to predict recurrence beyond standard clinicopathological variables, we calculated the change

292 perioperative data, including morbidity and clinicopathological variables, were analyzed.

293 stigate the predictive value of preoperative clinicopathological variables, with a special focus on a

294 al and nomograms derived using postoperative clinicopathological variables.

295 ned CTC biomarker expression with respect to clinicopathological variables.

296 COX-2 and HER2 expression/amplification and clinicopathological variables.

297 cs of TAMs were measured and correlated with clinicopathological variables.

298 d validation cohorts independent of standard clinicopathological variables.

299 s with CRCLM with added value to established clinicopathological variables.

300 We describe correlative clinicopathological/virological findings from a simian v